{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-23-000211","form_type":"8-K","ticker":"COSM","cik":"0001474167","company_name":"Cosmos Health Inc.","filed_at":"2023-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.149350+00:00","generated_at":"2026-06-20T15:57:59.089439+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"Cosmos Health extends LOI to acquire Cana Labs; renegotiates payment terms","bullets":["Updated binding LOI to acquire Greek pharma company Cana Laboratories; effective until May 31, 2023.","Acquisition price renegotiated with improved payment terms; no dollar amount disclosed.","Cana owns a 54,000 sq ft GMP-certified production facility in Athens, Greece.","Cana has partnerships with AstraZeneca, Merck, Medtronic, Nestle, and others.","CEO says acquisition would vertically integrate manufacturing and expand product portfolio."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-23-000211","json":"https://secwatch.observer/filing/0001477932-23-000211.json","markdown":"https://secwatch.observer/filing/0001477932-23-000211.md","text":"https://secwatch.observer/filing/0001477932-23-000211.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223000211/0001477932-23-000211-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223000211/cosm_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T15:57:59.089439+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}